Thymosin Alpha-1 (10mg)

$130.00

Thymosin Alpha-1 (10mg) is offered by Biotech Peptides for laboratory and analytical research. Thymosin Alpha-1 is a synthetic 28-residue peptide, also called thymalfasin, studied in relation to immune modulation, toll-like receptor signaling, and antiviral research. 1213

  • Product: Thymosin Alpha-1

  • Alternative name: Thymalfasin

  • Listed quantity: 10 mg

  • Reference molecular formula: C₁₂₉H₂₁₅N₃₃O₅₅

  • Intended use: Laboratory and analytical research only

Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.

For research use only. Not for human consumption.

SKU: Thymosin-Alpha-1-5-10mg Category:
Description

Thymosin Alpha-1 (10mg) for Laboratory Research

Thymosin Alpha-1 (10mg) is offered by Biotech Peptides for laboratories investigating immune modulation, toll-like receptor signaling, and antiviral research. Thymosin Alpha-1 is a synthetic 28-residue peptide, also called thymalfasin, that is identical to human thymosin alpha 1. 1213

For laboratories looking to buy Thymosin Alpha-1, this listing identifies a 10 mg quantity. Confirm the supplied material’s salt state, stereochemistry, and analytical characteristics against the requirements of the intended work.

Explore our research peptides for sale to review other laboratory-use listings.

Thymosin Alpha-1 Product Information

Property Listing information
Product name Thymosin Alpha-1
Alternative name Thymalfasin
Listed quantity 10 mg
Intended application Laboratory and analytical research
Documentation inquiries Include the product name and batch or lot number, where available

The 10 mg designation describes the quantity stated for this listing. It does not independently establish net peptide content or confirm that a particular quantity-assay method has been performed.

Thymosin Alpha-1 Reference Molecular Characteristics

The following characteristics describe the Thymosin Alpha-1 reference structure. They are not analytical confirmation of an individual commercial batch.

Reference characteristic Information
Peptide length 28 residues
Reference sequence Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH
Molecular formula C₁₂₉H₂₁₅N₃₃O₅₅
Approximate molecular weight 3108.3 g/mol
CAS number 62304-98-7
Chemical class Synthetic peptide

The sequence, molecular formula, molecular weight, and CAS number are documented in the PubChem Thymalfasin reference record and in the Thymosin Alpha-1 research summary. Confirm the supplied salt state and any counterions against manufacturer specifications before using reference values in analytical calculations. 1213

Thymosin Alpha-1 and Immune Research

A review of thymosin alpha 1 describes Tα1 as a 28 amino acid peptide originally isolated from the thymus, extensively studied in terms of its functions in the immune system. The same review notes that Tα1 functions as a toll-like receptor 9 and TLR-2 agonist in both myeloid and dendritic cells, the professional antigen-presenting cells. 1215

A separate study of thymosin alpha 1 and immune function reported that Tα1 + PCDs treatments increased DC activation and maturation. The investigators also reported that Tα1 + G2-S24P treatment increased co-receptor expression, intracellular IFNγ production in T cells, and elevated Treg functionality and reduced senescence. 1211

Read the review of thymosin alpha 1 for the molecular mechanisms and evidence limitations.

Antiviral Research

A randomized controlled clinical trial of thymosin alpha 1 and interferon alpha reported that a 6-month Tα1 therapy is safe and effective in arresting HBV replication. The investigators reported that nearly 60% of the treated patients became HBeAg- and HBV DNA-seronegative 6 months after the end of therapy. 1212

A separate study of thymosin alpha 1 and interferon alpha reported that a 6-month Tα1 therapy is effective and safe in patients with chronic hepatitis B. The investigators reported that Tα1 is able to reduce HBV DNA. 1223

These findings apply to specific patient populations and treatment protocols. They do not establish that a commercial Thymosin Alpha-1 batch treats hepatitis, cancer, or any other condition. 1212

Research Limitations

Published Thymosin Alpha-1 research examines receptor signaling, cell-based assays, and clinical studies in hepatitis and cancer. It does not establish that Thymosin Alpha-1 treats hepatitis, cancer, or any other condition. 1213

Published research also does not verify the identity, purity, quantity, or biological activity of the commercial batch supplied with this listing.

Documentation and Batch Verification

Before selecting Thymosin Alpha-1 (10mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:

  • Product name and batch or lot identifier.

  • Manufacturer specifications and chemical form.

  • Salt state and counterion information, where applicable.

  • Identity-testing methods and reported results.

  • Purity-testing methods and supporting analytical data.

  • Quantity or peptide-content measurements, where required.

  • Product-specific storage and handling instructions.

Match identifiers across the label, specifications, and analytical reports. Obtain clarification if the documentation uses inconsistent names, sequences, or molecular values.

For inquiries, provide “Thymosin Alpha-1 (10mg),” the batch number where available, and the specific information your laboratory requires.

Storage and Handling

Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.

Do not transfer storage temperatures, shelf-life claims, or preparation instructions from another supplier’s formulation or a differently modified peptide. Obtain clarification if documented instructions are unavailable or unclear.

Frequently Asked Questions About Thymosin Alpha-1 (10mg)

What is Thymosin Alpha-1?

Thymosin Alpha-1 is a synthetic 28-residue peptide, also called thymalfasin, that is identical to human thymosin alpha 1. 1213

Is Thymosin Alpha-1 the same as thymalfasin?

Yes. Thymosin Alpha-1 and thymalfasin refer to the same molecule. 1213

Does Thymosin Alpha-1 modulate immune function?

A review of thymosin alpha 1 describes Tα1 as a 28 amino acid peptide originally isolated from the thymus, extensively studied in terms of its functions in the immune system. This does not establish that a commercial Thymosin Alpha-1 batch modulates immune function in humans. 1213

What does the 10mg designation mean?

It is the quantity stated for this listing. It does not describe a concentration or independently establish net peptide content.

Does published research verify this product?

No. Publications describe the materials and conditions used by the investigators. Assess a commercial batch using relevant manufacturer specifications and analytical evidence.

Where can I find delivery information?

Review our shipping information for current order-processing and delivery terms.

Research Use Only

Thymosin Alpha-1 (10mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.

Review our Research-Use-Only Policy before ordering.

Additional information
BrandBiotech Peptides
Shipping & Delivery